Concepedia

Publication | Open Access

Results and insights from a phase I clinical trial of Lomecel‐B for Alzheimer's disease

66

Citations

38

References

2022

Year

Abstract

Our results support the safety of Lomecel-B for AD, suggest clinical potential, and provide mechanistic insights. This early-stage study provides important exploratory information for larger efficacy-powered clinical trials.

References

YearCitations

Page 1